Evidence map›Paper›PMID 34187934›Full record

ArticleLife science alliance2021

CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.

Kanako Nishiyama, Masashi Maekawa, Tomoya Nakagita, Jun Nakayama, Takeshi Kiyoi, Mami Chosei, Akari Murakami, Yoshiaki Kamei, Hiroyuki Takeda, Yasutsugu Takada and 1 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Autoantibody Profiling Using Human Autoantigen Protein Array and AlphaScreen.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kanako NishiyamaDepartment of Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Ehime University Graduate School of Medicine, Toon, Japan.
Masashi MaekawaDepartment of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Japan masashim@m.ehime-u.ac.jp.ORCID 0000-0002-9574-1906
Tomoya NakagitaDivision of Proteo-Drug-Discovery Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan.ORCID 0000-0002-0542-8650
Jun NakayamaDivision of Cellular Signaling, National Cancer Center Research Institute, Chuo-ku, Japan.ORCID 0000-0001-8844-4295
Takeshi KiyoiDivision of Analytical Bio-medicine, Advanced Research Support Center, Ehime University, Toon, Japan.
Mami ChoseiDivision of Cell Growth and Tumor Regulation, Proteo-Science Center, Ehime University, Toon, Japan.
Akari MurakamiDepartment of Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Ehime University Graduate School of Medicine, Toon, Japan.
Yoshiaki KameiDepartment of Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Ehime University Graduate School of Medicine, Toon, Japan.
Hiroyuki TakedaDivision of Proteo-Drug-Discovery Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Yasutsugu TakadaDepartment of Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Ehime University Graduate School of Medicine, Toon, Japan.ORCID 0000-0001-9743-1840
Shigeki HigashiyamaDepartment of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Japan shigeki@m.ehime-u.ac.jp.ORCID 0000-0002-2417-3921
Ehime University · JPOsaka International Cancer Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation drives HER2-positive breast cancer cell proliferation. Enforced activation of phosphatases for those receptors could be a therapeutic option for HER2-positive breast cancers. Here, we report that degradation of an endosomal small GTPase, RhoB, by the ubiquitin ligase complex cullin-3 (CUL3)/KCTD10 is essential for both EGFR and HER2 phosphorylation in HER2-positive breast cancer cells. Using human protein arrays produced in a wheat cell-free protein synthesis system, RhoB-GTP, and protein tyrosine phosphatase receptor type H (PTPRH) were identified as interacting proteins of connector enhancer of kinase suppressor of Ras1 (CNKSR1). Mechanistically, constitutive degradation of RhoB, which is mediated by the CUL3/KCTD10 E3 complex, enabled CNKSR1 to interact with PTPRH at the plasma membrane resulting in inactivation of EGFR phosphatase activity. Depletion of CUL3 or KCTD10 led to the accumulation of RhoB-GTP at the plasma membrane followed by its interaction with CNKSR1, which released activated PTPRH from CNKSR1. This study suggests a mechanism of PTPRH activation through the exclusive binding of RhoB-GTP to CNKSR1.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsCarrier ProteinsCell Line, TumorCullin ProteinsErb-b2 Receptor Tyrosine KinasesErbB ReceptorsFemaleGene Expression Regulation, NeoplasticHumansIntracellular Signaling Peptides and ProteinsMiddle AgedModels, BiologicalPhosphorylationCarrier ProteinsCNKSR1 protein, humanCUL3 protein, humanCullin ProteinsEGFR protein, humanERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesErbB ReceptorsIntracellular Signaling Peptides and ProteinsKCTD10 protein, humanPotassium Channels, Voltage-GatedReceptor-Like Protein Tyrosine Phosphatases, Class 3rhoB GTP-Binding Protein

Identifiers

PMID34187934
PMCPMC8321701
OpenAlexW3177049508

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.